News from the world
21
Mar
EU pharmaceutical policy: MEPs support comprehensive reform
MEPs adopted their proposals to revamp EU pharmaceutical legislation, to foster innovation and enhance...
20
Riforma farmaceutica: il Parlamento Ue non tocca (quasi) i tempi della tutela regolatoria
Nuovo codice del farmaco europeo: il Parlamento Ue potrebbe accettare di estendere a 7,5 anni la tutela...
15
US FDA Final Guidance: Controlled Correspondence Related to Generic Drug Development
FDA is committed to ensuring current and prospective abbreviated new drug application (ANDA) applicants...
FDA publishes artificial intelligence paper
FDA published its new paper, “Artificial Intelligence and Medical Products: How CBER, CDER, CDRH,...
latest news
21 Mar
20 Mar
15 Mar
14 Mar
Intelligenza artificiale: il Parlamento europeo ha approvato l’Ai Act
13 Mar
Efedrina e pseudoefedrina, nuove regole e sanzioni su export farmaci.
05 Mar
Why, Who, When, Where and More: New Draft Guidance on Notifying US FDA about Discontinuance or Interruption in Manufacturing
28 Feb
AIFA - Francesco Fera facente funzioni alla guida dell'Agenzia
1 2>>>